Literature DB >> 25314967

Temporal and spatial regulation of epsin abundance and VEGFR3 signaling are required for lymphatic valve formation and function.

Xiaolei Liu1, Satish Pasula2, Hoogeun Song2, Kandice L Tessneer2, Yunzhou Dong2, Scott Hahn2, Tadayuki Yago2, Megan L Brophy1, Baojun Chang2, Xiaofeng Cai2, Hao Wu2, John McManus2, Hirotake Ichise3, Constantin Georgescu4, Jonathan D Wren5, Courtney Griffin6, Lijun Xia1, R Sathish Srinivasan2, Hong Chen7.   

Abstract

Lymphatic valves prevent the backflow of the lymph fluid and ensure proper lymphatic drainage throughout the body. Local accumulation of lymphatic fluid in tissues, a condition called lymphedema, is common in individuals with malformed lymphatic valves. The vascular endothelial growth factor receptor 3 (VEGFR3) is required for the development of lymphatic vascular system. The abundance of VEGFR3 in collecting lymphatic trunks is high before valve formation and, except at valve regions, decreases after valve formation. We found that in mesenteric lymphatics, the abundance of epsin 1 and 2, which are ubiquitin-binding adaptor proteins involved in endocytosis, was low at early stages of development. After lymphatic valve formation, the initiation of steady shear flow was associated with an increase in the abundance of epsin 1 and 2 in collecting lymphatic trunks, but not in valve regions. Epsin 1 and 2 bound to VEGFR3 and mediated the internalization and degradation of VEGFR3, resulting in termination of VEGFR3 signaling. Mice with lymphatic endothelial cell-specific deficiency of epsin 1 and 2 had dilated lymphatic capillaries, abnormally high VEGFR3 abundance in collecting lymphatics, immature lymphatic valves, and defective lymph drainage. Deletion of a single Vegfr3 allele or pharmacological suppression of VEGFR3 signaling restored normal lymphatic valve development and lymph drainage in epsin-deficient mice. Our findings establish a critical role for epsins in the temporal and spatial regulation of VEGFR3 abundance and signaling in collecting lymphatic trunks during lymphatic valve formation.
Copyright © 2014, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25314967      PMCID: PMC4226761          DOI: 10.1126/scisignal.2005413

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  52 in total

Review 1.  Lymphangiogenesis in development and human disease.

Authors:  Kari Alitalo; Tuomas Tammela; Tatiana V Petrova
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

Review 2.  Molecular biology and pathology of lymphangiogenesis.

Authors:  Terhi Karpanen; Kari Alitalo
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

3.  Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature.

Authors:  R Sathish Srinivasan; Miriam E Dillard; Oleg V Lagutin; Fu-Jung Lin; Sophia Tsai; Ming-Jer Tsai; Igor M Samokhvalov; Guillermo Oliver
Journal:  Genes Dev       Date:  2007-10-01       Impact factor: 11.361

Review 4.  Developmental and pathological lymphangiogenesis: from models to human disease.

Authors:  Hélène Maby-El Hajjami; Tatiana V Petrova
Journal:  Histochem Cell Biol       Date:  2008-10-23       Impact factor: 4.304

5.  Flow shear stress stimulates Gab1 tyrosine phosphorylation to mediate protein kinase B and endothelial nitric-oxide synthase activation in endothelial cells.

Authors:  Zheng-Gen Jin; Chelsea Wong; Jie Wu; Bradford C Berk
Journal:  J Biol Chem       Date:  2005-01-21       Impact factor: 5.157

Review 6.  Lymphatic endothelial cells, lymphedematous lymphangiogenesis, and molecular control of edema formation.

Authors:  Rui-Cheng Ji
Journal:  Lymphat Res Biol       Date:  2008       Impact factor: 2.589

7.  Sox18 induces development of the lymphatic vasculature in mice.

Authors:  Mathias François; Andrea Caprini; Brett Hosking; Fabrizio Orsenigo; Dagmar Wilhelm; Catherine Browne; Karri Paavonen; Tara Karnezis; Ramin Shayan; Meredith Downes; Tara Davidson; Desmond Tutt; Kathryn S E Cheah; Steven A Stacker; George E O Muscat; Marc G Achen; Elisabetta Dejana; Peter Koopman
Journal:  Nature       Date:  2008-10-19       Impact factor: 49.962

Review 8.  The link between lymphatic function and adipose biology.

Authors:  Natasha L Harvey
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

9.  FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1.

Authors:  Camilla Norrmén; Konstantin I Ivanov; Jianpin Cheng; Nadine Zangger; Mauro Delorenzi; Muriel Jaquet; Naoyuki Miura; Pauli Puolakkainen; Valerie Horsley; Junhao Hu; Hellmut G Augustin; Seppo Ylä-Herttuala; Kari Alitalo; Tatiana V Petrova
Journal:  J Cell Biol       Date:  2009-04-27       Impact factor: 10.539

10.  Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting.

Authors:  Maria Wirzenius; Tuomas Tammela; Marko Uutela; Yulong He; Teresa Odorisio; Giovanna Zambruno; Janice A Nagy; Harold F Dvorak; Seppo Ylä-Herttuala; Masabumi Shibuya; Kari Alitalo
Journal:  J Exp Med       Date:  2007-05-29       Impact factor: 14.307

View more
  24 in total

1.  Selective Targeting of a Novel Epsin-VEGFR2 Interaction Promotes VEGF-Mediated Angiogenesis.

Authors:  H N Ashiqur Rahman; Hao Wu; Yunzhou Dong; Satish Pasula; Aiyun Wen; Ye Sun; Megan L Brophy; Kandice L Tessneer; Xiaofeng Cai; John McManus; Baojun Chang; Sukyoung Kwak; Negar S Rahman; Wenjia Xu; Conrad Fernandes; John Michael Mcdaniel; Lijun Xia; Lois Smith; R Sathish Srinivasan; Hong Chen
Journal:  Circ Res       Date:  2016-02-15       Impact factor: 17.367

2.  Insights from Genetic Model Systems of Retinal Degeneration: Role of Epsins in Retinal Angiogenesis and VEGFR2 Signaling.

Authors:  Yunzhou Dong; Xue Cai; Yong Wu; Yanjun Liu; Lin Deng; Hong Chen
Journal:  J Nat Sci       Date:  2017-01

Review 3.  Intestinal lymphatic vasculature: structure, mechanisms and functions.

Authors:  Jeremiah Bernier-Latmani; Tatiana V Petrova
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-06-28       Impact factor: 46.802

Review 4.  Lymphatic Vessel Network Structure and Physiology.

Authors:  Jerome W Breslin; Ying Yang; Joshua P Scallan; Richard S Sweat; Shaquria P Adderley; Walter L Murfee
Journal:  Compr Physiol       Date:  2018-12-13       Impact factor: 9.090

5.  Retrograde Lymph Flow Leads to Chylothorax in Transgenic Mice with Lymphatic Malformations.

Authors:  Maximilian Nitschké; Alexander Bell; Sinem Karaman; Meelad Amouzgar; Joseph M Rutkowski; Philipp E Scherer; Kari Alitalo; Donald M McDonald
Journal:  Am J Pathol       Date:  2017-07-03       Impact factor: 4.307

Review 6.  Endothelial epsins as regulators and potential therapeutic targets of tumor angiogenesis.

Authors:  Kai Song; Hao Wu; H N Ashiqur Rahman; Yunzhou Dong; Aiyun Wen; Megan L Brophy; Scott Wong; Sukyoung Kwak; Diane R Bielenberg; Hong Chen
Journal:  Cell Mol Life Sci       Date:  2016-08-29       Impact factor: 9.261

7.  Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib.

Authors:  Daniel J Crona; Andrew D Skol; Veli-Matti Leppänen; Dylan M Glubb; Amy S Etheridge; Eleanor Hilliard; Carol E Peña; Yuri K Peterson; Nancy Klauber-DeMore; Kari K Alitalo; Federico Innocenti
Journal:  Cancer Res       Date:  2018-11-01       Impact factor: 12.701

Review 8.  Biochemical and mechanical signals in the lymphatic vasculature.

Authors:  Xin Geng; Yen-Chun Ho; R Sathish Srinivasan
Journal:  Cell Mol Life Sci       Date:  2021-07-08       Impact factor: 9.261

Review 9.  Mechanisms and regulation of endothelial VEGF receptor signalling.

Authors:  Michael Simons; Emma Gordon; Lena Claesson-Welsh
Journal:  Nat Rev Mol Cell Biol       Date:  2016-07-27       Impact factor: 94.444

Review 10.  Epsins in vascular development, function and disease.

Authors:  Sudarshan Bhattacharjee; Bo Zhu; Yang Lee; Hao Wu; Yabing Chen; Hong Chen
Journal:  Cell Mol Life Sci       Date:  2020-09-15       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.